254 related articles for article (PubMed ID: 25781951)
1. Analysis of the role of interleukin 6 receptor haplotypes in the regulation of circulating levels of inflammatory biomarkers and risk of coronary heart disease.
Gigante B; Strawbridge RJ; Velasquez IM; Golabkesh Z; Silveira A; Goel A; Baldassarre D; Veglia F; Tremoli E; Clarke R; Watkins H; Hamsten A; Humphries SE; de Faire U
PLoS One; 2015; 10(3):e0119980. PubMed ID: 25781951
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies.
Pai JK; Mukamal KJ; Rexrode KM; Rimm EB
PLoS One; 2008 Jan; 3(1):e1395. PubMed ID: 18167554
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
; Swerdlow DI; Holmes MV; Kuchenbaecker KB; Engmann JE; Shah T; Sofat R; Guo Y; Chung C; Peasey A; Pfister R; Mooijaart SP; Ireland HA; Leusink M; Langenberg C; Li KW; Palmen J; Howard P; Cooper JA; Drenos F; Hardy J; Nalls MA; Li YR; Lowe G; Stewart M; Bielinski SJ; Peto J; Timpson NJ; Gallacher J; Dunlop M; Houlston R; Tomlinson I; Tzoulaki I; Luan J; Boer JM; Forouhi NG; Onland-Moret NC; van der Schouw YT; Schnabel RB; Hubacek JA; Kubinova R; Baceviciene M; Tamosiunas A; Pajak A; Topor-Madry R; Malyutina S; Baldassarre D; Sennblad B; Tremoli E; de Faire U; Ferrucci L; Bandenelli S; Tanaka T; Meschia JF; Singleton A; Navis G; Mateo Leach I; Bakker SJ; Gansevoort RT; Ford I; Epstein SE; Burnett MS; Devaney JM; Jukema JW; Westendorp RG; Jan de Borst G; van der Graaf Y; de Jong PA; Mailand-van der Zee AH; Klungel OH; de Boer A; Doevendans PA; Stephens JW; Eaton CB; Robinson JG; Manson JE; Fowkes FG; Frayling TM; Price JF; Whincup PH; Morris RW; Lawlor DA; Smith GD; Ben-Shlomo Y; Redline S; Lange LA; Kumari M; Wareham NJ; Verschuren WM; Benjamin EJ; Whittaker JC; Hamsten A; Dudbridge F; Delaney JA; Wong A; Kuh D; Hardy R; Castillo BA; Connolly JJ; van der Harst P; Brunner EJ; Marmot MG; Wassel CL; Humphries SE; Talmud PJ; Kivimaki M; Asselbergs FW; Voevoda M; Bobak M; Pikhart H; Wilson JG; Hakonarson H; Reiner AP; Keating BJ; Sattar N; Hingorani AD; Casas JP
Lancet; 2012 Mar; 379(9822):1214-24. PubMed ID: 22421340
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women.
Qi L; Rifai N; Hu FB
Diabetes; 2009 Jan; 58(1):275-8. PubMed ID: 18852330
[TBL] [Abstract][Full Text] [Related]
5. Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men.
Ken-Dror G; Drenos F; Humphries SE; Talmud PJ; Hingorani AD; Kivimäki M; Kumari M; Bauer KA; Morrissey JH; Ireland HA
J Thromb Haemost; 2010 Nov; 8(11):2394-403. PubMed ID: 20735728
[TBL] [Abstract][Full Text] [Related]
6. Family-based association study of interleukin 6 (IL6) and its receptor (IL6R) functional polymorphisms in schizophrenia in the Polish population.
Kapelski P; Skibinska M; Maciukiewicz M; Pawlak J; Permoda-Osip A; Twarowska-Hauser J
J Neuroimmunol; 2015 Aug; 285():62-7. PubMed ID: 26198920
[TBL] [Abstract][Full Text] [Related]
7. Association of two variants in the interleukin-6 receptor gene and premature coronary heart disease in a Chinese Han population.
Chen Z; Qian Q; Tang C; Ding J; Feng Y; Ma G
Mol Biol Rep; 2013 Feb; 40(2):1021-6. PubMed ID: 23073775
[TBL] [Abstract][Full Text] [Related]
8. A novel haplotype within C-reactive protein gene influences CRP levels and coronary heart disease risk in Northwest Indians.
Singh P; Singh M; Nagpal HS; Kaur T; Khullar S; Kaur G; Dhillon H; Di Napoli M; Mastana S
Mol Biol Rep; 2014 Sep; 41(9):5851-62. PubMed ID: 24965144
[TBL] [Abstract][Full Text] [Related]
9. Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation.
CRP CHD Genetics Collaboration
Eur J Epidemiol; 2008; 23(8):531-40. PubMed ID: 18425592
[TBL] [Abstract][Full Text] [Related]
10. An association study between genetic polymorphism in the interleukin-6 receptor gene and coronary heart disease.
Zhou J; Chen X; Ye H; Peng P; Ba Y; Yang X; Huang X; Lu Y; Jiang X; Lian J; Duan S
Biomed Res Int; 2014; 2014():504727. PubMed ID: 24971337
[TBL] [Abstract][Full Text] [Related]
11. IL6R haplotype rs4845625*T/rs4537545*C is a risk factor for simultaneously high CRP, LDL and ApoB levels.
Arguinano AA; Naderi E; Ndiaye NC; Stathopoulou M; Dadé S; Alizadeh B; Visvikis-Siest S
Genes Immun; 2017 Sep; 18(3):163-169. PubMed ID: 28769070
[TBL] [Abstract][Full Text] [Related]
12. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.
Drenos F; Talmud PJ; Casas JP; Smeeth L; Palmen J; Humphries SE; Hingorani AD
Hum Mol Genet; 2009 Jun; 18(12):2305-16. PubMed ID: 19336475
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and coronary heart disease in western Turkey.
Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
[TBL] [Abstract][Full Text] [Related]
14. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.
Yanbaeva DG; Dentener MA; Spruit MA; Houwing-Duistermaat JJ; Kotz D; Passos VL; Wouters EF
BMC Med Genet; 2009 Mar; 10():23. PubMed ID: 19272152
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
[TBL] [Abstract][Full Text] [Related]
17. The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study.
Patterson CC; Smith AE; Yarnell JW; Rumley A; Ben-Shlomo Y; Lowe GD
Atherosclerosis; 2010 Apr; 209(2):551-7. PubMed ID: 19836021
[TBL] [Abstract][Full Text] [Related]
18. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
19. Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study.
Cai T; Zhang Y; Ho YL; Link N; Sun J; Huang J; Cai TA; Damrauer S; Ahuja Y; Honerlaw J; Huang J; Costa L; Schubert P; Hong C; Gagnon D; Sun YV; Gaziano JM; Wilson P; Cho K; Tsao P; O'Donnell CJ; Liao KP;
JAMA Cardiol; 2018 Sep; 3(9):849-857. PubMed ID: 30090940
[TBL] [Abstract][Full Text] [Related]
20. A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia.
Huusko JM; Karjalainen MK; Mahlman M; Haataja R; Kari MA; Andersson S; Toldi G; Tammela O; Rämet M; Lavoie PM; Hallman M;
BMC Med Genet; 2014 Nov; 15():120. PubMed ID: 25409741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
